Showing results (221-230 of 241) with videos related to
Sort By:
Pageof 25
Vox Sanguinis|August 31, 2021
Babesia microti in a Canadian blood donor and lookback in a red blood cell recipientSteven J Drews, Paul Van Caeseele, Jared Bullard, et al.Journal of Neurology|May 26, 2001
HLA-DRB1 and disease outcome in multiple sclerosisS J Weatherby, W Thomson, L Pepper, et al.Journal of Travel Medicine|September 26, 2019
Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysisAndrea K Boggild, Eric Caumes, Martin P Grobusch, et al.Neuron|June 9, 2014
SorCS2 regulates dopaminergic wiring and is processed into an apoptotic two-chain receptor in peripheral gliaSimon Glerup, Ditte Olsen, Christian B Vaegter, et al.European Journal of Neurology|March 9, 2022
Diagnosis, differential diagnosis and misdiagnosis of Susac syndromeJames D Triplett, Jessica Qiu, Billy O'Brien, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.Annals of Internal Medicine|May 12, 2015
Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance NetworkAndrea K Boggild, Douglas H Esposito, Phyllis E Kozarsky, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.Journal of Neurology|November 5, 2015
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromesMaciej Juryńczyk, Brian Weinshenker, Gulsen Akman-Demir, et al.Pageof 25